The Hyderabad-based firm has received technology for the next-gen live, attenuated oral vaccine to combat cVDPV2 outbreaks from PT BioFarma of Indonesia The Hyderabad-based firm has received technology for the next-gen live, attenuated oral vaccine to combat cVDPV2 outbreaks from PT BioFarma of Indonesia Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
WHO grants pre-qualification status to Biological E.’s novel oral polio vaccine type 2
